Skip to content

Clinical effect of Jianpi Lishi Jiedu Decoction on postoperative patients with spleen deficiency and dampness toxin type colorectal adenoma

Clinical effect of Jianpi Lishi Jiedu Decoction on postoperative patients with spleen deficiency and dampness toxin type colorectal adenoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004576
Enrollment
Unknown
Registered
2021-03-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal adenoma

Interventions

Sponsors

Nanjing Integrated Traditional Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Colonoscopic diagnosis of colorectal polyps, histopathological examination consistent with adenoma, adenoma clipping or endoscopic resection treatment, and TCM syndrome consistent with spleen deficiency and dampness toxin syndrome; 2. Aged from 18 to 65 years old, male or female; 3. The patient fully informed consent and completely voluntary observation, and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. It does not meet the diagnostic criteria of colorectal polyps or pathology does not meet the diagnostic criteria of TCM Syndromes of adenoma or spleen deficiency and dampness toxin syndrome; 2. Pregnant or lactating women or those preparing for childbirth; 3. Patients with allergic constitution or allergic to multiple drugs; 4. Patients with severe diseases of heart, lung, liver, kidney and blood system; 5. Patients with suspected canceration or canceration by biopsy.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of colorectal adenoma;Main symptoms of Patiens;Curative effect of TCM Syndrome;Safety indicators (such as routine hematuria feces, liver and kidney function, ECG);Beta-catenin;

Secondary

MeasureTime frame
Secondary symptoms of patients;

Countries

China

Contacts

Public ContactWanli Liu

Nanjing Integrated Traditional Chinese and Western Medicine Hospital

18951768998@163.com+86 18502506688

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026